'Tamper-evident' benefits are evident
2019 will mark Uniplast's debut at this year's edition of CPHI Worlwide in Frankfurt, where it will showcase its expertise in plastic packaging.
Pharmaceutical packaging serves numerous purposes and comes in a variety of materials and designs, depending on the drug product.
Uniplast - a regional leader in the manufacture and distribution of pharmaceutical, medical and cosmetic packaging - has used its 27 years of operational expertise and knowhow to develop more than 150 different high-quality products.
Tamper-proof bottles that save time and reduce contamination
The company is renowned for its variety of plastic packaging, particularly its bottles with a tamper-proof cap and integrated dropper, which reduces the packaging process from three to two steps, thereby saving time in product filling and packing, and reduces the risk of contamination while handling the sterile products. These plastic bottles are used for storing liquid pharmaceutical products (magistral medicine, galenical medicine, ready-made medicines, and pharmaceutical substance) and can be in direct contact with the product. Customers can choose the colour of the container
Compliance and certification
Demonstrating its compliance with various regulatory standards, Uniplast's plastic containers and closures are manufactured in accordance with the following: ISO 9001, ISO 14001, OHSAS 18001 and ISO 15378. In 2017, Uniplast implemented ISO 13485, regarding the production, development and sale of sterile and nonsterile IVDs, urine cups, Petri dishes, and swab and faeces containers.
The Uniplast team's creative environment motivates and inspires all those that are in touch with their products and services. Uniplast customers can expect a relationship based on 100% trust and fair co-operation to ensure superior quality products that will improve their sales and facilitate the way to success.
Related News
-
News CPHI Frankfurt: Interview with Marcelo Cruz, Vice President, Business Development & Marketing at Tjoapack
In this series of interviews, we caught up with some of the exhibitors at CPHI Frankfurt to discover what innovations are being brought to the pharmaceutical industry this year. Here we chat with Marcelo Cruz of Tjoapack to discuss how global events ar... -
News CPHI Frankfurt 2022: Innovator Interviews – Bioiberica
In this series of interviews, we speak to the companies on the CPHI Frankfurt show floor who are driving innovation in pharma for a better healthcare future. We caught up with Mónica Gómez Navarro (Marketing Manager Branded Ingredients), ... -
News CPHI Frankfurt 2022: Innovator Interview – Procaps Group
In this series of interviews, we speak to the companies on the CPHI Frankfurt show floor who are driving innovation in pharma for a better healthcare future. We interviewed Rosella Del Vecchio Herrera, Marketing Director at Procaps Group, to discover h... -
News From the floor - CPHI Frankfurt 2022
The live blog from the people on the ground at CPHI Frankfurt - covering all stand-out news, memorable moments, and keynote updates from the 2022 event. -
News How to Commercialise an Advanced Therapy: Connect to Frankfurt on-demand
In this Connect to Frankfurt session, Andrea Zobel, Senior Director, Personalized Supply Chain at World Courier (Berlin Germany), Melissa Lattanzi, VP Emerging Therapies at AmerisourceBergen (King of Prussia, USA), and Hans-Peter Scherzer, Customer Suc... -
News CDMO - Health is a Joint Project: Connect to Frankfurt on-demand
In this Connect to Frankfurt session, Emanuele Agnese, Business Development Manager and Pietro Allegrini, R&D Director at Indena, present the ways in which a reliable manufacturing partner in the pursuit of better health outcomes for patients and pharm... -
News Streamlined Development for Efficient Production of Bispecific Molecules: Connect to Frankfurt on-demand
In this Connect to Frankfurt session, Séverine Fagète, VP, Cell Line Development Services at Selexis (Geneva, Switzerland), and Brandon Brino (Durham, USA), Process Development Scientist and Group Leader at KBI Biopharma, present an overv... -
News MDR – How to collect post-market clinical follow-up data (PMCF): Connect to Frankfurt on-demand
In this Connect to Frankfurt session, Philipp Annecke, Junior Key Account Manager and Heinrich Martens, VP Regulatory Affairs of Fresenius Kabi (Bad Homburg, Germany) present guidances from the Medical Devices Regulation on clinical data evaluatio...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance